Kornam (Terazosin)

Terazosin selectively blocks alpha‑1 adrenergic receptors on vascular smooth muscle and in the prostate. This inhibition prevents norepinephrine‑induced contraction, leading to vasodilation that lowers blood pressure and to reduced tone in the prostate and bladder neck, improving urinary flow.

The exact dose of Kornam is determined by the prescribing clinician based on the individual’s condition, response, and tolerance. Physicians typically start with a low dose and titrate upward as needed, following local prescribing guidelines.

Safety of terazosin in pregnancy and lactation has not been established. It should be avoided unless the potential benefit justifies the potential risk to the fetus or infant, and only under direct medical supervision.

To order Kornam, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

For hypertension, terazosin is one of several alpha‑1 blockers, whereas other classes such as ACE inhibitors or calcium channel blockers act via different mechanisms. In BPH, alternatives like tamsulosin also target alpha‑1 receptors but may have different side‑effect profiles. Choice depends on patient comorbidities, tolerability and physician preference.

Store Kornam at ambient temperature, preferably below 25 °C, in its original packaging. Protect the tablets from moisture, excessive heat and direct sunlight to maintain potency and stability.

Kornam is taken orally, usually with a glass of water. The tablet should be swallowed whole and not crushed or chewed unless otherwise directed by a healthcare professional.

Serious risks include severe hypotension leading to fainting, priapism (a prolonged painful erection), and rare allergic reactions such as anaphylaxis. Patients should seek immediate medical attention if they experience sudden dizziness, chest pain, or any signs of an allergic response.

Kornam is contraindicated in patients with known hypersensitivity to terazosin or any component of the formulation, in those with severe liver disease, and in individuals who are already taking other potent alpha‑blockers without medical supervision. Caution is also advised for patients with a history of orthostatic hypotension.